Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR1I3 |
| Upstream (Parents) |
|---|
| (<<) VTN → NR1I3 |
| (<<) HLF → NR1I3 |
| (<<) SALL1 → NR1I3 |
| (<<) NR1H4 → NR1I3 |
| Downstream (Children) |
|---|
| NR1I3 → HOXB13 (>>) |
| NR1I3 → CUX2 (>>) |
| NR1I3 → ONECUT1 (>>) |
| NR1I3 → ESR1 (>>) |
| NR1I3 → GLI2 (>>) |
| NR1I3 → GATA4 (>>) |
| NR1I3 → ATF5 (>>) |
| NR1I3 → LHX2 (>>) |
| NR1I3 → HHEX (>>) |
| NR1I3 → KLF15 (>>) |
| NR1I3 → AR (>>) |
| NR1I3 → CDKN2A (>>) |
| NR1I3 → MMP14 (>>) |
| NR1I3 → NR5A2 (>>) |
| NR1I3 → NPAS2 (>>) |
| NR1I3 → HOXD9 (>>) |
| NR1I3 → HOXA2 (>>) |
| NR1I3 → TCF3 (>>) |
| NR1I3 → MAFF (>>) |
| NR1I3 → HOXA4 (>>) |
| NR1I3 → NR4A1 (>>) |
| NR1I3 → RORC (>>) |
| NR1I3 → ZGPAT (>>) |
| NR1I3 → RORA (>>) |
| NR1I3 → NR3C2 (>>) |
| NR1I3 → PEG3 (>>) |
| NR1I3 → HCFC1 (>>) |
| NR1I3 → ONECUT2 (>>) |
| NR1I3 → PROX1 (>>) |
| NR1I3 → CEBPA (>>) |
| NR1I3 → HMGB2 (>>) |
| NR1I3 → CITED2 (>>) |
| NR1I3 → TBX3 (>>) |
| NR1I3 → RXRA (>>) |
| NR1I3 → HMBOX1 (>>) |
| NR1I3 → ELF1 (>>) |
